If anyone is attending this year's AGM, I would appreciate it if they could ask a question or two on my behalf.
Specifically, I would like a question asked about the timing of the FDA clinical trial and the capital raising that will proceed it. Last year we were blind-sided by a capital raising the day after the AGM which was incredibly poor timing and disclosure.
Additionally, the company said in its latest press release that most of the questions that the CHMP asked had been completely answered to the satisfaction of the committee. Are the questions that remain un-answered material in affecting a positive opinion from the CHMP at the 210 day milestone?
I'll throw a third one in for good measure. I would love to know whether the company is of the opinion (based off the communications between themselves and the CHMP) of not receiving CE Mark once the process comes to its conclusion.
Many thanks to anyone who asks
GL
TIS Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
